Healthcare Services

Endometriosis market forecast through 2030 with growth insights

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Endometriosis Market In 2026 And 2030?

The endometriosis market has shown substantial growth recently. It is projected to expand from $1.54 billion in 2025 to $1.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.0%. Historically, this growth has stemmed from factors including the underdiagnosis of endometriosis, an increase in gynecological consultations, a rise in infertility cases, the adoption of hormonal therapy, and the demand for pain management.

The endometriosis market is expected to demonstrate robust expansion over the next few years. It is predicted to attain a value of $2.44 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.8%. This growth during the forecast period is fueled by early detection initiatives, improved accuracy in diagnosis, personalized therapeutic approaches, heightened advocacy for women’s health, and the proliferation of specialized care facilities. Prominent trends anticipated in this period include increased awareness of chronic pelvic pain, a rise in diagnoses of fertility-related disorders, broader utilization of hormonal therapies, the expansion of specialty gynecology centers, and a concentrated focus on managing the disease long-term.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

What Key Factors Are Shaping The Endometriosis Market Landscape?

The rising prevalence of ovarian cancer is anticipated to boost the growth of the endometriosis market. Ovarian cancer originates in the ovaries, which are female reproductive organs responsible for producing eggs and hormones like estrogen and progesterone. Endometriosis is connected to an elevated risk of developing epithelial ovarian cancer, especially the endometrioid and precise cell cancer subtypes, which are characterized by high estrogen levels that can heighten the risk of ovarian cancer. For instance, in January 2023, the American Cancer Society, a US-based professional organization, projected approximately 19,710 new cases of ovarian cancer among women in the US for 2023. Additionally, in 2022, the Ovarian Cancer Research Alliance, a US-based not-for-profit organization, reported 12,810 deaths due to ovarian cancer, a number expected to rise to 13,270 fatalities in 2023. Consequently, the increasing incidence of ovarian cancer is propelling the expansion of the endometriosis market.

How Are Different Segments Classified In The Endometriosis Market Segment Analysis?

The endometriosis market covered in this report is segmented –

1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types

2) By Treatment Type: Hormonal Therapy, Pain Management

3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs

4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users

Subsegments:

1) By Superficial Peritoneal Lesion: Minimal Lesions, Mild Lesions, Peritoneal Surface Lesions

2) By Endometrioma: Ovarian Endometrioma, Chocolate Cyst, Bilateral Endometrioma

3) By Deeply Infiltrating Endometriosis: Rectovaginal Deep Lesions, Bladder Deep Lesions, Ureteral Deep Lesions

4) By Other Types: Adenomyosis-Associated Endometriosis, Extraperitoneal Endometriosis, Rare Anatomical Site Endometriosis

What Market Trends Are Affecting The Endometriosis Market?

Major companies in the endometriosis market are developing innovative solutions, including non-invasive diagnostic assays, to improve early detection and patient management. Non-invasive diagnostic assays are tests designed to detect or monitor a disease without requiring surgery or the insertion of instruments into the body, often utilizing samples such as blood, urine, saliva, or imaging. For instance, in July 2025, Kephera Diagnostics LLC, a US-based diagnostic laboratory, launched EndomTest, an innovative blood-based diagnostic test for endometriosis. EndomTest functions as a laboratory-developed test that analyzes a patient’s serum sample for the biomarkers Brain-Derived Neurotrophic Factor (BDNF) and Cancer Antigen 125 (CA125), then combines these biomarker results with selected clinical variables using a proprietary diagnostic algorithm to generate a positive or negative “rule-in” indication for endometriosis. Its unique characteristics include a non-surgical sampling method (just a blood draw), high specificity (reported at nearly 100%) for identifying the disease, and clinical applications that cover women presenting with pelvic pain, heavy menstrual bleeding, infertility, or dyspareunia.

Who Are The Companies Driving Activity In The Endometriosis Market?

Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., Abbvie Inc., Bayer AG, GlaxoSmithKline plc, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Gedeon Richter plc, Torrent Pharmaceuticals Ltd., Ferring Pharmaceuticals, Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., Repros Therapeutics Inc., Myovant Sciences Ltd., Takeda Pharmaceutical Company Limited, ObsEva SA, Gesynta Pharma AB, Zydus Healthcare Limited

Get The Full Endometriosis Market Report:

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

Which Region Leads The Endometriosis Market In Terms Of Market Share?

North America was the largest region in the endometriosis market in 2025. The regions covered in the endometriosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Endometriosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

Browse Through More Reports Similar to the Global Endometriosis Market 2026, By The Business Research Company

Uterine Fibroids Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/uterine-fibroids-treatment-global-market-report

Endometrial Cancer Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/endometrial-cancer-treatment-global-market-report

Endometrial Ablation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/endometrial-ablation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795